These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37060825)

  • 21. Down-regulation of a panel of immune-related lncRNAs in breast cancer.
    Ghafouri-Fard S; Asadi M; Sohrabi B; Arsang-Jang S; Mehravaran E; Taheri M; Samsami M
    Pathol Res Pract; 2021 Aug; 224():153534. PubMed ID: 34175685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Treg-associated lncRNAs in breast cancer.
    Moallemi-Rad L; Ghorbani A; Dadyar M; Hussen BM; Rasul MF; Eslami S; Taheri M; Jamali E; Ghafouri-Fard S
    Pathol Res Pract; 2023 Jan; 241():154270. PubMed ID: 36535227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the expression pattern of mTOR-associated lncRNAs and their genomic variants in the patients with breast cancer.
    Taherian-Esfahani Z; Taheri M; Dashti S; Kholghi-Oskooei V; Geranpayeh L; Ghafouri-Fard S
    J Cell Physiol; 2019 Dec; 234(12):22044-22056. PubMed ID: 31062358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer.
    Yaghoobi H; Azizi H; Oskooei VK; Taheri M; Ghafouri-Fard S
    World J Surg Oncol; 2018 Oct; 16(1):211. PubMed ID: 30336781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression analysis of autophagy-related long non-coding RNAs in Iranian patients with breast cancer.
    Safarzadeh A; Akhavan-Bahabadi M; Hussen BM; Nicknam A; Eslami S; Pouresmaeili F; Ghafouri-Fard S; Taheri M
    Pathol Res Pract; 2022 Nov; 239():154146. PubMed ID: 36195025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression analysis of growth arrest specific 8 and its anti-sense in breast cancer tissues.
    Dashti S; Taherian-Esfahani Z; Kholghi-Oskooei V; Ghafouri-Fard S; Taheri M
    Exp Mol Pathol; 2020 Jun; 114():104414. PubMed ID: 32165089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulated long non-coding RNA SNHG7 restricts proliferation and boosts apoptosis of nasopharyngeal carcinoma cells by elevating microRNA-140-5p to suppress GLI3 expression.
    Dai Y; Zhang X; Xing H; Zhang Y; Cao H; Sang J; Gao L; Wang L
    Cell Cycle; 2020 Feb; 19(4):448-463. PubMed ID: 31944163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer.
    Zhang Y; Yuan Y; Zhang Y; Cheng L; Zhou X; Chen K
    Cell Cycle; 2020 Jan; 19(1):142-152. PubMed ID: 31814518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
    An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
    Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y; Zhao F; Zhang Z; Sun F; Wang M
    Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA SNHG7 represses the expression of RBM5 to strengthen metastasis of hepatocellular carcinoma.
    Sun BZ; Ji DG; Feng ZX; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5699-5704. PubMed ID: 31298322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines.
    Jafari-Oliayi A; Asadi MH
    Cell Oncol (Dordr); 2019 Apr; 42(2):211-221. PubMed ID: 30826970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway.
    Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J
    Pathol Res Pract; 2019 Feb; 215(2):302-307. PubMed ID: 30527358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway.
    Sun X; Huang T; Liu Z; Sun M; Luo S
    Eur J Pharmacol; 2019 Aug; 856():172407. PubMed ID: 31132353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
    Zhong X; Long Z; Wu S; Xiao M; Hu W
    J BUON; 2018; 23(3):776-781. PubMed ID: 30003751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2653-2661. PubMed ID: 29771415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA (LncRNA) SNHG7/ Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) involves in the malignant events of ovarian cancer cells with paclitaxel resistant.
    Zhang J; Zhang R; Ye Y
    Bioengineered; 2021 Dec; 12(2):10541-10552. PubMed ID: 34709112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non coding RNA COX10-DT promotes the progression of breast cancer via the COX10-DT/miR-206/BDNF axis.
    Sun J; Li X; Yin J; Chen X; Zhu Z; Wu R; Yu E; Mao Z
    Biochem Biophys Res Commun; 2023 Jan; 639():46-53. PubMed ID: 36463760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA SNHG7 promotes migration and invasion of melanoma via upregulating SOX4.
    Zhang C; Zhu B; Li XB; Cao YQ; Yang JC; Li X; Liu YX; Wang YB
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4828-4834. PubMed ID: 31210315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers.
    Sanchez Calle A; Yamamoto T; Kawamura Y; Hironaka-Mitsuhashi A; Ono M; Tsuda H; Shimomura A; Tamura K; Takeshita F; Ochiya T; Yamamoto Y
    Mol Oncol; 2020 Sep; 14(9):2271-2287. PubMed ID: 32392629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.